Results 171 to 180 of about 2,002,341 (191)
Some of the next articles are maybe not open access.
Yttrium-90 Radioembolization for the Treatment of Liver Metastases
2006There is a significant body of evidence supporting the safety and effectiveness of radioembolization in the treatment of metastases to the liver. The aforementioned studies representing the collective clinical experience supporting the safety and therapeutic benefit of TheraSphere and SIR-Spheres in patients with metastatic disease to the liver suggest
Riad Salem +2 more
openaire +1 more source
Radiation Pneumonitis after Yttrium-90 Radioembolization: A Systematic Review
Journal of Vascular and Interventional RadiologyTo evaluate the available evidence of lung dosimetry and radiation pneumonitis (RP).The guideline regarding the maximum tolerated lung dose for yttrium-90 (90Y) radioembolization is an expert opinion (Level 5 evidence) based on a case series of 5 patients and recommends keeping the absorbed radiation dose to the lungs below 30 Gy per treatment and 50 ...
Bela Kis, Marcell Gyano
openaire +2 more sources
Yttrium 90 Radioembolization-Induced Cirrhosis
American Journal of Gastroenterology, 2018Faizi Hai +2 more
openaire +1 more source
Yttrium-90 Radioembolization for Breast Cancer Liver Metastases
Journal of Vascular and Interventional Radiology, 2016Andrew C, Gordon +2 more
openaire +2 more sources
The Limitations of Theoretical Dose Modeling for Yttrium-90 Radioembolization
Journal of Vascular and Interventional Radiology, 2014David, Liu +3 more
openaire +2 more sources
Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases
Journal of Vascular and Interventional Radiology, 2018Shou-En Lu, Bin Gui, Darren R. Carpizo
exaly